Abstract
Artemisinin, a sesquiterpene lactone derived from the sweet wormwood plant Artemisia annua, and its bioactive derivatives exhibit potent anticancer effects in a variety of human cancer cell model systems. The pleiotropic response in cancer cells includes growth inhibition by cell cycle arrest, apoptosis, inhibition of angiogenesis, disruption of cell migration, and modulation of nuclear receptor responsiveness. These effects of artemisinin and its derivatives result from perturbations of many cellular signalling pathways. This review provides a comprehensive discussion of these cellular responses, and considers the ramifications for the potential development of artemisinin-based compounds in anticancer therapeutic and preventative strategies.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Anti-Infective Agents / chemistry
-
Anti-Infective Agents / pharmacology*
-
Anti-Infective Agents / therapeutic use
-
Apoptosis / drug effects
-
Apoptosis / physiology
-
Apoptosis Regulatory Proteins / metabolism*
-
Artemisia annua / chemistry
-
Artemisinins / chemistry
-
Artemisinins / pharmacology*
-
Artemisinins / therapeutic use
-
Cell Cycle / drug effects*
-
Cell Cycle / physiology
-
Cell Movement / drug effects
-
Cell Movement / physiology
-
Humans
-
Neoplasms / drug therapy
-
Neoplasms / metabolism*
-
Neovascularization, Pathologic / metabolism
-
Signal Transduction / drug effects
-
Transferrin / metabolism
-
Tumor Suppressor Protein p53 / metabolism
-
p38 Mitogen-Activated Protein Kinases / metabolism
Substances
-
Anti-Infective Agents
-
Apoptosis Regulatory Proteins
-
Artemisinins
-
Transferrin
-
Tumor Suppressor Protein p53
-
artemisinin
-
p38 Mitogen-Activated Protein Kinases